一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (410k)
Article in Japanese

Case Report

A case of pulmonary cryptococcosis during the use of baricitinib

Keisuke Kanekoa,b  Jun Kanazawab  Takefumi Saitob  Yuko Minamic  Shintaro Suzukia  Hironori Sagaraa 

aDivision of Allergology and Respiratory Medicine, Department of Internal Medicine, Showa University School of Medicine
bInternal Medicine Clinical Department Respiratory Medicine, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities
cDepartment of Pathological Diagnosis, National Hospital Organization Ibarakihigashi National Hospital, The Center of Chest Diseases and Severe Motor & Intellectual Disabilities

ABSTRACT

A 69-year-old man who received baricitinib and salazosulfapyridine for treatment of rheumatoid arthritis developed left-sided chest pain and was admitted to our hospital for further evaluation and treatment. Chest radiography revealed an infiltrative shadow in the left lower lung and chest computed tomography revealed scattered nodular shadows predominantly in the left lower lobe. Serum cryptococcal antigen test results were positive. Evaluation of bronchoscopy specimens showed Cryptococcus neoformans and the patient was diagnosed with pulmonary cryptococcosis. We administered fluconazole, which led to both symptomatic and radiographic improvement. Janus kinase (JAK) inhibitors have increasingly been used as immunosuppressants in recent years; however, few studies have reported cryptococcosis associated with their use. We report a rare case of JAK inhibitor-induced cryptococcosis.

KEYWORDS

Pulmonary cryptococcosis  Baricitinib  Janus kinase inhibitor  Biological drug  Fluconazole (FCZ) 

Received 7 Oct 2022 / Accepted 11 Jan 2023

AJRS, 12(2): 88-92, 2023

Google Scholar